# Pliant Therapeutics, Inc.: Form 8-K, filed Jun 14, 2024

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2024-06-14
- Accepted by EDGAR: Jun 14, 2024, 20:04 ET
- Period: 2024-06-13
- Accession: 0001746473-24-000084
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/plrx-20240613.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/plrx-20240613.htm

Filed Jun 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001746473-24-000084. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.